Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 143982-54-1 | MDL No. : | MFCD05864806 |
Formula : | C10H9BrN2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | MPILHKPXTMEIMG-UHFFFAOYSA-N |
M.W : | 269.10 | Pubchem ID : | 15152339 |
Synonyms : |
|
Num. heavy atoms : | 15 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.2 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 58.98 |
TPSA : | 43.6 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.57 cm/s |
Log Po/w (iLOGP) : | 2.2 |
Log Po/w (XLOGP3) : | 3.34 |
Log Po/w (WLOGP) : | 2.27 |
Log Po/w (MLOGP) : | 1.64 |
Log Po/w (SILICOS-IT) : | 1.76 |
Consensus Log Po/w : | 2.24 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.86 |
Solubility : | 0.0373 mg/ml ; 0.000138 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.93 |
Solubility : | 0.0314 mg/ml ; 0.000117 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.42 |
Solubility : | 0.102 mg/ml ; 0.00038 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.27 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 1170568-70-3 ]
Ethyl 3-bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate hydrochloride
Similarity: 0.81
[ 749849-14-7 ]
6-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid
Similarity: 0.77
[ 878197-68-3 ]
5-Bromoimidazo[1,2-a]pyridine-2-carbaldehyde
Similarity: 0.76
[ 1026201-45-5 ]
8-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid
Similarity: 0.75
[ 1260763-32-3 ]
Ethyl 6-bromo-8-fluoroimidazo[1,2-a]pyridine-2-carboxylate
Similarity: 0.75
[ 158980-21-3 ]
Ethyl 6-aminoimidazo[1,2-a]pyridine-2-carboxylate
Similarity: 0.84
[ 1170568-70-3 ]
Ethyl 3-bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate hydrochloride
Similarity: 0.81
[ 214958-32-4 ]
Ethyl 6-iodoimidazo[1,2-a]pyridine-2-carboxylate
Similarity: 0.78
[ 38923-08-9 ]
Ethyl 6-nitroimidazo[1,2-a]pyridine-2-carboxylate
Similarity: 0.76
[ 367500-93-4 ]
Ethyl 6-fluoroimidazo[1,2-a]pyridine-2-carboxylate
Similarity: 0.76
[ 158980-21-3 ]
Ethyl 6-aminoimidazo[1,2-a]pyridine-2-carboxylate
Similarity: 0.84
[ 1170568-70-3 ]
Ethyl 3-bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate hydrochloride
Similarity: 0.81
[ 214958-32-4 ]
Ethyl 6-iodoimidazo[1,2-a]pyridine-2-carboxylate
Similarity: 0.78
[ 64951-08-2 ]
Imidazo[1,2-a]pyridine-2-carboxylic acid
Similarity: 0.77
[ 749849-14-7 ]
6-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid
Similarity: 0.77